NDC Package 65757-725-00 Risperidone

Injection, Suspension - View Billable Units, 11-Digit Format, RxNorm

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
65757-725-00
Package Description:
4 TRAY in 1 CARTON / 160 VIAL in 1 TRAY / 2 mL in 1 VIAL
Product Code:
Non-Proprietary Name:
Risperidone
Substance Name:
Risperidone
Usage Information:
Risperidone is used to treat a certain mental/mood disorder called schizophrenia. This medication can decrease hallucinations, help you to think more clearly and positively about yourself, feel less agitated, and take a more active part in everyday life. Risperidone is an antipsychotic drug (atypical type). It works by helping to restore the balance of certain natural substances in the brain.
11-Digit NDC Billing Format:
65757072500
Product Type:
Drug For Further Processing
Labeler Name:
Alkermes, Inc.
Dosage Form:
Injection, Suspension - A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa.
Active Ingredient(s):
Sample Package:
N/A
Marketing Category:
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date:
10-29-2003
Listing Expiration Date:
12-31-2024
Exclude Flag:
N
Unfinished Product:
Yes
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 65757-725-00?

The NDC Packaged Code 65757-725-00 is assigned to an UNFINISHED drug package of 4 tray in 1 carton / 160 vial in 1 tray / 2 ml in 1 vial of Risperidone, drug for further processing labeled by Alkermes, Inc.. The product's dosage form is injection, suspension and is administered via form.

Is NDC 65757-725 included in the NDC Directory?

Yes, Risperidone is an UNFINISHED PRODUCT with code 65757-725 that is active and included in the NDC Directory. The product was first marketed by Alkermes, Inc. on October 29, 2003 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 65757-725-00?

The 11-digit format is 65757072500. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-265757-725-005-4-265757-0725-00